News

DOD Awards Contracts to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS' 500 Million Free At-Home COVID-19 Tests
January 14, 2022 — Today, the Department of Defense (DoD), in coordination with the U.S. Department of Health and Human Services (HHS), awarded contracts to Abbott Rapid Dx North America, LLC (Orlando, Florida), iHealth Lab Inc. (Mountain View, California), and Roche Diagnostics Corporation (Indianapolis, Indiana), purchasing a combined total of 380 million over-the-counter COVID-19 test kits. The DoD’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) led this effort in partnership with DoD’s Defense Assisted Acquisition Cell (DA2), Army Contracting Command, and the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR)... MORE

American flags against a blue sky background

DOD Awards Contracts to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS' 500 Million Free At-Home COVID-19 Tests
January 10, 2022 — This weekend, the Department of Defense (DoD), in coordination with the U.S. Department of Health and Human Services (HHS), awarded contracts to Atlantic Trading, LLC (Austin, Texas) and Medea Inc. (Pleasanton, California), purchasing a combined total of 27 million over-the-counter COVID-19 test kits. The DoD’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) led this effort in partnership with DoD’s Defense Assisted Acquisition Cell (DA2), Army Contracting Command, and the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR). ... MORE

In the foreground a hand holding an orange sticker that says "I got my vaccine". In the background there are three medical personnel wearing personal protective equipment.

DOD Awards $51.6 Million Contract to Goldbelt Security LLC to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS' 500 Million Free At-Home COVID-19 Tests
January 7, 2022 — On Jan. 6, 2022, the Department of Defense (DoD), in coordination with the U.S. Department of Health and Human Services (HHS), awarded a $51.6 million contract to Goldbelt Security, LLC, located in Newport News, Virginia, for delivery of over-the-counter COVID-19 test kits. This effort supports the president’s plan to deliver 500 million at-home COVID-19 tests to the nation at no cost in response to the Omicron variant. The DoD’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) led this effort in partnership with DoD’s Defense Assisted Acquisition Cell (DA2), Army Contracting Command, and the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR). The procurement was funded through the American Rescue Plan Act to supply critical medical resources to the Nation. ... MORE

Two uniformed service members are in a tent. One wears PPE and a faceshield, while they use a nasal swab to collect a COVID-19 sample from the other Service member in uniform.

DOD Awards Contract to Revival Health Inc. to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS' 500 Million Free At-Home COVID-19 Tests
January 7, 2022 — On Jan. 7, 2022, the Department of Defense (DoD), in coordination with the U.S. Department of Health and Human Services (HHS), awarded a contract to Revival Health Inc., located in Manhattan Beach, California, to procure 13.3 million over-the-counter COVID-19 test kits. The DoD's Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) led this effort in partnership with DoD's Defense Assisted Acquisition Cell (DA2), Army Contracting Command, and the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR)... MORE

DOD Awards $136.7 Million Contract to MilliporeSigma to Establish Domestic Production Capacity of Critical Material Used in COVID-19 Point-of-Care Tests
December 30, 2021 — On Dec. 29, 2021, the Department of Defense (DOD), on behalf of and in coordination with the U.S. Department of Health and Human Services, awarded a $136.7 million contract to MilliporeSigma to establish nitrocellulose membrane production capacity in the United States. The DOD’s Defense Assisted Acquisition Cell (DA2) led this effort in coordination with the Department of the Air Force’s Acquisition COVID-19 Task Force (DAF ACT) supported by the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) who facilitates the DA2’s Screening & Diagnostics industrial base expansion efforts. This effort was funded through the American Rescue Plan Act (ARPA) to support domestic industrial base expansion for critical medical resources... MORE

Biden Administration Secures 10 Million Courses of Pfizer’s COVID-19 Oral Antiviral Medicine as Additional Tool to Reduce Hospitalizations and Save Lives
November 18, 2021 — As part of its ongoing efforts to curb the pandemic, reduce hospitalizations, and save lives, the Biden Administration has secured 10 million treatment courses of Pfizer’s promising COVID-19 oral antiviral drug, contingent on emergency use authorization (EUA) or approval from the U.S. Food and Drug Administration (FDA)... MORE

JPM CBRN Medical Announces RPP in Support of Vaccine Acceleration Program
November 15, 2021 — The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear (CBRN) Defense’s (JPEO-CBRND) Joint Project Manager for CBRN Medical (JPM CBRN Medical), in collaboration with the JPEO-CBRND’s Joint Project Lead for CBRN Defense Enabling Biotechnologies (JPL CBRND EB), and the U.S. Department of Health and Human Services’ (HHS) Biomedical Advanced Research and Development Authority (BARDA), released a request for prototype proposal (RPP) on November 10, 2021, soliciting offers for mRNA vaccine development through December 13, 2021. These offers will include mRNA vaccine design, non-clinical testing, and clinical testing against priority biological threats. ... MORE

JPEO-CBRND Team and Partners Win Five Defense Acquisition Workforce Awards
November 12, 2021 — The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) celebrates its teammates and partners who collectively won five 2021 Defense Acquisition Workforce Awards for their work at the organization... MORE

Winners from the 2021 Defense Acquisition Workforce Award include LTC John Nuckols, Dr. Kevin Wingerd, JPEO-CBRND, U.S. Air Force, COVID-19 USTRANSCOM JUON TC-0003 Response, and U.S. Army, Operation Warp Speed and the JPEO-CBRND Medical Repurposing Team.

CB Defense Today with guest Dr. Jason Roos
November 9, 2021 — CB Defense Today is a quarterly recorded interview, where CBC Director, Dr. Eric L. Moore talks with other leaders across the CB Defense Enterprise. This September Dr. Moore’s guest was Joint Program Executive Officer for CBRND, Dr. Jason Roos. The two discussed the valuable partnership between CBC and JPEO for Chemical, Biological, Radiological and Nuclear Defense, pandemic preparedness in the chemical biological defense space, and improving warfighter protection and decontamination in the field based on future operating environments... MORE

Screenshot of CB Defense Today with guest Dr. Jason Roos

Newly Confirmed Assistant Secretary of Defense, Other DOD Officials Make Inaugural Visit to JPEO-CBRND
November 5, 2021 — Ms. Deborah Rosenblum, the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs (ASD(NCB)) and several other DOD officials visited the headquarters of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear (CBRN) Defense (JPEO-CBRND) at the Aberdeen Proving Ground - Edgewood, Md., on Monday, October 25, 2021. This was Ms. Rosenblum’s first visit to JPEO-CBRND after her Senate confirmation vote on July 29, 2021. ... MORE

News Search

News Archive - Search by Year and Month

2025 (7)
2024 (40)
2023 (36)
2022 (31)
2021 (37)
2020 (15)
2019 (11)
2018 (5)
2017 (9)
2016 (1)

JPEO-CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.

JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.

The information contained in these articles has been reviewed and approved for public release.

The appearance of hyperlinks does not constitute endorsement by the JPEO-CBRND of non-U.S. government sites or the information, products, or services contained therein. Although the JPEO-CBRND may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all the information that you may find at these locations. Such hyperlinks are provided consistent with the stated purpose of this website.